Prime Medicine Inc (PRME)
8.035
+0.50
(+6.71%)
USD |
NASDAQ |
May 21, 16:00
8.035
0.00 (0.00%)
After-Hours: 17:15
Prime Medicine Accounts Payable (Quarterly): 10.08M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 10.08M |
| December 31, 2023 | 19.54M |
| September 30, 2023 | 14.12M |
| June 30, 2023 | 5.49M |
| March 31, 2023 | 4.561M |
| Date | Value |
|---|---|
| December 31, 2022 | 4.332M |
| September 30, 2022 | 4.111M |
| June 30, 2022 | 5.885M |
| December 31, 2021 | 1.435M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.435M
Minimum
Dec 2021
19.54M
Maximum
Dec 2023
7.728M
Average
5.49M
Median
Jun 2023
Accounts Payable (Quarterly) Benchmarks
| Pacific Biosciences of California Inc | 21.01M |
| 10x Genomics Inc | 20.22M |
| Recursion Pharmaceuticals Inc | 5.115M |
| Verve Therapeutics Inc | 3.049M |
| Ginkgo Bioworks Holdings Inc | 27.00M |